Results 141 to 150 of about 580,024 (350)

Mechanostimulatory Cues Determine Intestinal Fibroblast Fate and Profibrotic Remodeling in a Physiodynamic Human Gut‐on‐a‐Chip

open access: yesAdvanced Science, EarlyView.
A healthy gut barrier shields underlying fibroblasts from luminal shear forces, illustrating that “good fences make good neighbors.” Barrier damage exposes fibroblasts to shear stress, inducing cell death and the emergence of stress‐adapted, profibrotic fibroblasts. Sustained shear exposure promotes the formation of stiff aggregates of mechanoadapative
Soyoun Min   +6 more
wiley   +1 more source

Role of Tumour Necrosis Factor Alpha (TNFa) in ischaemic and pharmacological postconditioning

open access: yes, 2010
Includes bibliographical references (leaves 158-192).Ischaemic postconditioning (IPostC) is a powerful protective mechanism that activates prosurvival intrinsic signalling cascades to limit reperfusion injury but the exact signalling pathway involved in ...
Lacerda, Lydia
core  

PRMT1‐Mediated LDHA Methylation Drives STAT3 Lactylation to Orchestrate Intestinal Inflammation and Tumorigenesis

open access: yesAdvanced Science, EarlyView.
This study identifies an immunometabolic axis wherein SAM‐driven PRMT1 methylates LDHA, enhancing its activity. The resultant lactate induces STAT3 K709 lactylation, which stabilizes an active conformation to promote STAT3 phosphorylation and IL‐10 expression.
Hui Wang   +12 more
wiley   +1 more source

PET Imaging of Cardiac Inflammation in Viral Myocarditis Using a DPP4‐Targeted Probe

open access: yesAdvanced Science, EarlyView.
This study describes a DPP4‐targeted PET probe for imaging myocardial inflammation by selectively targeting activated immune cells. Derived from the clinically approved small‐molecule inhibitor linagliptin, the probe demonstrates favorable biodistribution with specific cardiac uptake in myocarditis.
Wanhao Gao   +14 more
wiley   +1 more source

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1997
A. Wilson   +4 more
semanticscholar   +1 more source

Association of increased levels of plasma tumor necrosis factor alpha with primary open-angle glaucoma

open access: yes, 2018
Altaf A Kondkar, Tahira Sultan, Faisal A Almobarak, Hatem Kalantan, Saleh A Al-Obeidan, Khaled K Abu-Amero Glaucoma Research Chair, Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia Purpose: Retinal ganglion ...
Kalantan H   +5 more
core  

Canagliflozin Alleviates Diabetic Glomerular Endothelial Injury via Melibiose in a Microbiota‐Dependent Manner

open access: yesAdvanced Science, EarlyView.
Canagliflozin treatment reshapes the gut microbiota in DKD and elevates levels of melibiose, a metabolite derived from Roseburia intestinalis. Melibiose directly binds to and enhances the enzymatic activity of glyoxalase 1, leading to decreased methylglyoxal accumulation.
Wei Zhang   +32 more
wiley   +1 more source

Elevated levels of plasma tumor necrosis factor alpha in patients with pseudoexfoliation glaucoma

open access: yes, 2018
Altaf A Kondkar,1 Taif A Azad,1 Faisal A Almobarak,1 Hatem Kalantan,1 Saleh A Al-Obeidan,1 Khaled K Abu-Amero1,2 1Glaucoma Research Chair, Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 2Department of ...
Kalantan H   +5 more
core  

Ankylosing Spondilitis in a Patient with Hepatitis Reactivation Treated with Anti-tumor Necrosis Factor Alpha: A Case Report [PDF]

open access: yes
Ankylosing spondylitis (AS), a type of spondyloarthropathy, is an autoimmune disease characterized by inflammation that mostly affects soft tissues, such as the axial skeleton, sacroiliac joint, tendons, and ligaments.
Duygu Geler Külcü   +3 more
core   +1 more source

Anti-Tumor Necrosis Factor Alpha Treatment and Tuberculin Skin Test

open access: yesÇukurova Üniversitesi Tıp Fakültesi Dergisi, 2015
Purpose: The use of anti-tumor necrosis factor alpha (anti-TNF) drugs has been a milestone in the treatment of rheumatic diseases. Despite their strong efficacy, there are some factors restricting the use of anti-TNF agents. We must be careful especially
Emine Duygu Ersozlu Bozkirli   +3 more
doaj  

Home - About - Disclaimer - Privacy